Отчет об анализе размера, доли и тенденций мирового рынка средств для контроля хирургических инфекций – обзор отрасли и прогноз до 2031 года

Анализ рынка средств для контроля хирургических инфекций

Рынок контроля инфекций в месте хирургического вмешательства (SSI) стремительно развивается из-за растущей осведомленности о профилактике инфекций и достижений в области медицинских технологий. Рынок, движимый растущим числом хирургических процедур и растущим вниманием к безопасности пациентов, включает такие продукты, как антимикробные шовные материалы, решения для профилактики инфекций и хирургические простыни. Ключевые разработки включают интеграцию современных антимикробных материалов в хирургические инструменты и использование инновационных методов стерилизации для улучшения контроля инфекций. Компании инвестируют в исследования с целью разработки более эффективных продуктов для профилактики SSI и улучшения существующих технологий. Кроме того, рост числа внутрибольничных инфекций привел к ужесточению правил и более широкому принятию протоколов контроля инфекций. Ожидается, что такие факторы будут стимулировать рост рынка и инновации, что приведет к лучшим результатам и снижению уровня инфекций в хирургических учреждениях.

Размер рынка средств для контроля хирургических инфекций

Объем мирового рынка контроля хирургических инфекций в 2023 году оценивался в 5,92 млрд долларов США, а к 2031 году, по прогнозам, он достигнет 9,57 млрд долларов США, при среднегодовом темпе роста 6,19% в прогнозируемый период с 2024 по 2031 год. Помимо аналитических данных о рыночных сценариях, таких как рыночная стоимость, темпы роста, сегментация, географический охват и основные игроки, рыночные отчеты, подготовленные Data Bridge Market Research, также включают углубленный экспертный анализ, эпидемиологию пациентов, анализ конвейера, анализ цен и нормативно-правовую базу.

Тенденции рынка контроля хирургических инфекций

« Внедрение современных антимикробных покрытий и технологий»

The surgical site infection (SSI) control market is rapidly evolving due to the increasing focus on enhancing patient safety and improving surgical outcomes, noticeable by the trending adoption of advanced antimicrobial coatings and technologies for surgical instruments and medical devices. Such innovative solutions aim to minimize the risk of infections by providing continuous protection against a broad spectrum of pathogens. For instance, silver-ion antimicrobial coatings have demonstrated effectiveness in reducing bacterial colonization on surgical tools, thereby lowering SSI rates. Such a trend reflects a broader shift towards integrating cutting-edge materials and technologies into surgical practices to enhance infection control protocols and improve overall patient care. The market is witnessing significant growth as healthcare facilities invest in these advanced solutions to meet stringent infection control standards and reduce healthcare-associated infections.

Report Scope and Surgical Site Infection Control Market Segmentation         

Surgical Site Infection Control Market Definition

Surgical Site Infection (SSI) Control refers to the strategies and practices implemented to prevent infections at the site of a surgical procedure. Strategies and practices encompasses a range of measures, including preoperative sterilization and antiseptic protocols, the use of prophylactic antibiotics, sterile surgical techniques, and post-operative wound care. Effective SSI control aims to reduce the incidence of infections, promote faster healing, and improve overall surgical outcomes by maintaining a clean and safe environment throughout the surgical process.

Surgical Site Infection Control Market Dynamics

Drivers

• Increasing Number Of Surgical Procedures

The increasing number of surgical procedures globally is a significant driver for the SSI control market. According to the World Health Organization (WHO), approximately 234 million major surgical procedures are performed annually worldwide. This surge in surgical activities correlates with a higher risk of infections, emphasizing the need for effective SSI control measures. The growing volume of surgeries, both elective and emergency, amplifies the demand for advanced infection control technologies and protocols to mitigate these risks and improve patient outcomes. Such a trend underscores the critical role of effective SSI prevention strategies in managing the growing burden associated with surgical interventions.

• Innovations in Antimicrobial Technologies

Innovations in antimicrobial technologies are revolutionizing infection prevention in surgical settings, providing more robust and targeted solutions to combat SSIs. Antimicrobial coatings for surgical instruments, such as those incorporating silver or iodine, effectively inhibit microbial growth on surfaces, drastically reducing the risk of infections. Advanced wound dressings, such as those embedded with bioactive agents such as honey or antimicrobial peptides, offer sustained protection and accelerate healing. Additionally, new antiseptic solutions, including formulations with enhanced concentrations of chlorhexidine gluconate, offer superior efficacy in preoperative skin disinfection. Such advancements collectively enhance infection control measures, leading to improved patient outcomes and reduced healthcare-associated complications. Consequently fostering the surgical site infection control market.

Opportunities

• Increased Focus on Patient Safety

The heightened focus on patient safety has significantly influenced the investment in SSI prevention technologies and practices. According to the Patient Safety Network - Agency for Healthcare Research and Quality, more than one million Healthcare-associated infections (HAIs) occur across the United States healthcare system every year. Such alarming statistics has led to a strong emphasis on improving the quality of care, prompting healthcare facilities to invest in advanced SSI prevention measures. For instance, hospitals that have implemented comprehensive infection control programs, including the use of advanced antimicrobial technologies and rigorous preoperative protocols. Furthermore, the Centers for Disease Control and Prevention (CDC) supports these efforts through its guidelines and initiatives aimed at enhancing infection prevention practices, thereby reinforcing the commitment to safeguarding patient health ,thus creating significant opportunities in the innovative SSI control solutions.

• Wearable Technologies Enhancing Surgical Site Infection Control

Wearable technologies designed to monitor and analyze infection risks in real-time present a significant opportunity in the surgical site infection (SSI) control market. For instance, the TempTraq wearable temperature monitoring patch continuously tracks body temperature and transmits data to healthcare providers. Wearable improvised devices can detect deviations from normal temperature ranges, potentially indicating an infection, and promptly alert medical staff. Research has demonstrated that early detection through such wearables can lead to earlier treatment interventions, significantly reducing the risk of complications and hospitalizations. As healthcare facilities increasingly focus on reducing SSIs, the integration of such real-time monitoring technologies represents a valuable market opportunity for advancing infection control strategies and improving patient outcomes in surgical settings.

Restraints/Challenges

• High Costs Associated With Advanced Infection Control

The high costs associated with advanced infection control products and technologies can be a substantial barrier for healthcare facilities with limited budgets. For instance, sophisticated systems such as automated UV-C disinfection units and advanced air filtration systems can be prohibitively expensive, especially when considering the additional costs for installation, maintenance, and staff training. Smaller or financially constrained healthcare facilities may find these expenses challenging to manage, which can limit their ability to adopt essential infection control measures and, consequently, affect patient safety and care quality.

• Emergence Of Antibiotic Resistance

Antibiotic resistance presents a critical challenge in infection control, as the emergence of resistant pathogens reduces the efficacy of standard prophylactic measures. For instance, the Centers for Disease Control and Prevention (CDC) reports that over 2.8 million people in the U.S. are affected by antibiotic-resistant infections each year, with more than 35,000 fatalities. Methicillin-resistant Staphylococcus aureus (MRSA) is a prominent instance of such issue, known for its resistance to commonly used antibiotics, which exacerbates the difficulty in controlling infections and underscores the urgent need for enhanced infection control practices and the development of new antimicrobial agents. The increased prevalence of such resistant strains complicates infection control efforts, making it more difficult to manage and prevent surgical site infections effectively, and necessitates the development of alternative strategies and new antimicrobial agents. Consequently hampering the surgical site infection control market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Surgical Site Infection Control Market Scope

The market is segmented on the type of infection, procedure, product, end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type of Infection

• Deep Incisional SSI (Surgical Site Infection)
• Organ or Space SSI
• Superficial Incisional SSI

Procedure

• Caesarean Section
• Gastric Bypass
• Cataract Surgery
• Dental Restoration
• Others

Product

• Surgical Scrubs
• Surgical Irrigation
• Hair Clippers
• Skin Preparation Solution
• Surgical Gloves
• Medical Nonwovens
• Surgical Drapes
• Manual Reprocesses Solution
  • Disinfectants
  • Hand Disinfectants
• Others

End Users

• Ambulatory Surgical Centres
• Hospitals
• Clinics
• Others

Surgical Site Infection Control Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type of infection, procedure, product, end users.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the surgical site infection control market, driven by advanced healthcare infrastructure and increasing awareness about the critical need to manage surgical site infections effectively. Additionally, the region benefits from significant investments in infection prevention technologies and stringent regulatory standards, further fueling its dominance.

The Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by an increase in surgical procedures due to the rising prevalence of chronic diseases. Additionally, improving healthcare infrastructure and growing investments in medical technology are further contributing to the region's market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Surgical Site Infection Control Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Surgical Site Infection Control Market Leaders Operating in the Market Are:

• 3M (U.S.)
• BD (Becton, Dickinson and Company) (U.S.)
• ANSELL LTD. (Australia)
• Sotera Health (U.S.)
• Medtronic (Ireland)
• Belimed AG (Switzerland)
• BIOMÉRIEUX (France)
• Getinge (Sweden)
• STERIS (U.S.)
• Lac-Mac Limited (Canada)
• Pacon Manufacturing (U.S.)
• AMERICAN POLYFILM, INC. (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Covalon Technologies Ltd. (Canada)
• Stryker (U.S.)
• Mölnlycke AB (Sweden)
• Prescient Surgical (U.S.)
• PAUL HARTMANN AG (Германия)

Последние разработки на рынке контроля инфекций в области хирургического вмешательства

• В апреле 2022 года Mölnlycke расширила свое глобальное присутствие, построив новую фабрику по производству хирургических перчаток в Малайзии. Этот стратегический шаг направлен на расширение производственных возможностей компании, гарантируя, что они смогут удовлетворить растущий спрос на перчатки Biogel, ключевой продукт в их портфолио
• В марте 2022 года компания Invenio представила серию хирургических халатов V90, разработанную для повышения защиты и комфорта медицинских работников во время хирургических процедур. Эта новая серия представляет собой шаг вперед в стремлении Invenio предоставлять высококачественную и надежную медицинскую одежду.

SKU-35574